{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:07Z","timestamp":1793500087509,"version":"4.5.0"},"reference-count":52,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH132401"],"award-info":[{"award-number":["R01MH132401"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,12,10]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Demand for a future HIV vaccine, similar to other vaccines, is vulnerable to misinformation. A number of studies have examined HIV vaccine acceptability and demand, but few have systematically explored the specific concerns and misinformation that shape these attitudes. This structured review and content analysis of published and grey literature identifies concerns about the HIV vaccine that might fuel misinformation about the vaccine when it is available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted across multiple publication databases and Google Scholar with a search strategy that used a combination of keywords. A web search was also conducted to identify other unpublished sources. Articles, including published and grey literature such as reports, were included if they were published in English and contained HIV vaccine concerns or misinformation. There was no defined timeline for article inclusion. HIV vaccine concerns extracted from the literature were documented in an Excel database and coded using NVivo V.12. Content analysis revealed several distinct topics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From a total of 78 articles and 9 reports, 333 concerns were extracted and included in the analysis. Seven topics emerged: (1) HIV vaccine safety, including concerns about side effects; (2) HIV vaccine causing HIV infection; (3) vaccine-related stigma and social concerns; (4) behavioural implications of the HIV vaccine, including concerns that the vaccine promotes risky behaviours; (5) conspiracy theories about the vaccine fuelled by distrust in governments and scientists; (6) concerns about partial efficacy of the vaccine and (7) HIV vaccine access, including eligibility for and availability of the vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review highlights key concerns about an HIV vaccine, many of which are both influenced by misinformation and could seed future misinformation campaigns. The findings can inform targeted interventions to counter misinformation and communicate the vaccine\u2019s preventive benefits to populations at highest risk of HIV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-020730","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:35:14Z","timestamp":1767879314000},"page":"e020730","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Characterising concerns and misinformation shaping global HIV vaccine confidence and demand: a structured literature search and content analysis"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4372-5266","authenticated-orcid":false,"given":"Simamkele","family":"Bokolo","sequence":"first","affiliation":[{"name":"Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand Johannesburg Faculty of Health Sciences, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Rabin","sequence":"additional","affiliation":[{"name":"Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Penuela-Wermers","sequence":"additional","affiliation":[{"name":"Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-9586","authenticated-orcid":false,"given":"Candice Maylene","family":"Chetty-Makkan","sequence":"additional","affiliation":[{"name":"Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand Johannesburg Faculty of Health Sciences, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teniola I","family":"Egbe","sequence":"additional","affiliation":[{"name":"Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Thirumurthy","sequence":"additional","affiliation":[{"name":"Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Maughan-Brown","sequence":"additional","affiliation":[{"name":"Southern Africa Labour and Development Research Unit, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Buttenheim","sequence":"additional","affiliation":[{"name":"Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2026010805350669000_11.1.e020730.1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijregi.2022.08.009","article-title":"HIV and adolescent girls and young women in sub-Saharan Africa: A call for expedited action to reduce new infections","volume":"5","author":"Murewanhema","year":"2022","journal-title":"IJID Reg"},{"key":"2026010805350669000_11.1.e020730.2","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2352-3018(20)30232-0","article-title":"The case for an HIV cure and how to get there","volume":"8","author":"Dybul","year":"2021","journal-title":"Lancet HIV"},{"key":"2026010805350669000_11.1.e020730.3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/hiv.70024","article-title":"mRNA vaccines against HIV: Hopes and challenges","volume":"26","author":"Zubair","year":"2025","journal-title":"HIV Med"},{"key":"2026010805350669000_11.1.e020730.4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10142-025-01613-1","article-title":"New hope and promise with CRISPR-Cas9 technology for the treatment of HIV","volume":"25","author":"Hassan","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"2026010805350669000_11.1.e020730.5","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70121","article-title":"Current Challenges With Highly Active Antiretroviral Therapy and New Hope and Horizon With CRISPR-CAS9 Technology for HIV Treatment","volume":"105","author":"Zubair","year":"2025","journal-title":"Chem Biol Drug Des"},{"key":"2026010805350669000_11.1.e020730.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-09785-0","article-title":"Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important","volume":"20","author":"Laher","year":"2020","journal-title":"BMC Public Health"},{"key":"2026010805350669000_11.1.e020730.7","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v16i1.4476"},{"key":"2026010805350669000_11.1.e020730.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-024-03516-y","article-title":"Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review","volume":"24","author":"Admassu","year":"2024","journal-title":"BMC Womens Health"},{"key":"2026010805350669000_11.1.e020730.9","unstructured":"Friedhoff S . What is vaccine demand? Brown University S of PH. n.d. Available: https:\/\/globalepidemics.org\/2022\/05\/13\/what-is-vaccine-demand\/"},{"key":"2026010805350669000_11.1.e020730.10","unstructured":"Vaccine Confidence Project . State of vaccine confidence in the EU. 2018."},{"key":"2026010805350669000_11.1.e020730.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012433","article-title":"Predictors of COVID-19 vaccine uptake among adults in South Africa: multimethod evidence from a population-based longitudinal study","volume":"8","author":"Maughan-Brown","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2026010805350669000_11.1.e020730.12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40271-024-00686-7","article-title":"Perceptions and Acceptance of a Prophylactic Vaccine for Human Immunodeficiency Virus (HIV): A Qualitative Study","volume":"17","author":"Aldhouse","year":"2024","journal-title":"Patient"},{"key":"2026010805350669000_11.1.e020730.13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7196\/SAMJ.2023.v113i1.16670","article-title":"Exploring a community\u2019s understanding of HIV vaccine\u2011induced seropositivity in a South African research setting","volume":"113","author":"Malahleha","year":"2023","journal-title":"S Afr Med J"},{"key":"2026010805350669000_11.1.e020730.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026010805350669000_11.1.e020730.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000179454.93443.60"},{"key":"2026010805350669000_11.1.e020730.16","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2012.692388"},{"key":"2026010805350669000_11.1.e020730.17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2989\/16085900609490362","article-title":"Vaccine preparedness: lessons from Lyantonde, Uganda","volume":"5","author":"Ritvo","year":"2006","journal-title":"Afr J AIDS Res"},{"key":"2026010805350669000_11.1.e020730.18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.24248\/eahrj.v4i2.636","article-title":"What motivates or demotivates injecting drug users to participate in hypothetical HIV vaccine efficacy trials? A qualitative study from urban Tanzania","volume":"4","author":"Iseselo","year":"2020","journal-title":"East Afr Health Res J"},{"key":"2026010805350669000_11.1.e020730.19","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00009"},{"key":"2026010805350669000_11.1.e020730.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-09202-6","article-title":"Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada","volume":"20","author":"Fleming","year":"2020","journal-title":"BMC Public Health"},{"key":"2026010805350669000_11.1.e020730.21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17290376.2018.1536561","article-title":"\u2018Why would you promote something that is less percent safer than a condom?\u2019: Perspectives on partially effective HIV prevention technologies among key populations in South Africa","volume":"15","author":"Rubincam","year":"2018","journal-title":"SAHARA J"},{"key":"2026010805350669000_11.1.e020730.22","doi-asserted-by":"publisher","DOI":"10.1177\/1090198107305078"},{"key":"2026010805350669000_11.1.e020730.23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.vaccine.2010.10.076","article-title":"\u201cOnce Bitten, Twice Shy\u201d: participant perspectives in the aftermath of an early HIV vaccine trial termination","volume":"29","author":"Newman","year":"2011","journal-title":"Vaccine (Auckl)"},{"key":"2026010805350669000_11.1.e020730.24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1"},{"key":"2026010805350669000_11.1.e020730.25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1353\/hpu.2007.0061","article-title":"Breaking the Silence: What Homeless 18- to 24-Year-Olds Say about HIV Vaccine Trials","volume":"18","author":"Koniak","year":"2007","journal-title":"Hpu"},{"key":"2026010805350669000_11.1.e020730.26","doi-asserted-by":"publisher","DOI":"10.1076\/jmep.27.2.197.2986"},{"key":"2026010805350669000_11.1.e020730.27","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411190-00003"},{"key":"2026010805350669000_11.1.e020730.28","doi-asserted-by":"publisher","DOI":"10.1080\/09540120701855375"},{"key":"2026010805350669000_11.1.e020730.29","doi-asserted-by":"publisher","DOI":"10.1177\/1090198109335654"},{"key":"2026010805350669000_11.1.e020730.30","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.17.4.253.66529"},{"key":"2026010805350669000_11.1.e020730.31","doi-asserted-by":"publisher","DOI":"10.1258\/0956462054679232"},{"key":"2026010805350669000_11.1.e020730.32","unstructured":"IAVI . Myths & misconceptions. 2008."},{"key":"2026010805350669000_11.1.e020730.33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-1"},{"key":"2026010805350669000_11.1.e020730.34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11121-013-0371-0","article-title":"Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials","volume":"15","author":"Andrasik","year":"2014","journal-title":"Prev Sci"},{"key":"2026010805350669000_11.1.e020730.35","first-page":"143","article-title":"HIV vaccine acceptability among African American women","volume":"13","author":"Opoku-Dapaah","year":"2020","journal-title":"J Best Pract Health Prof Divers"},{"key":"2026010805350669000_11.1.e020730.36","first-page":"1662","article-title":"HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion","volume":"97","author":"Roberts","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"2026010805350669000_11.1.e020730.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000127064.84325.ad"},{"key":"2026010805350669000_11.1.e020730.38","unstructured":"HIV Vaccine Trial Network . HIV study vaccines: myths and facts. 2022. Available: https:\/\/rochestervictoryalliance.org\/wp-content\/uploads\/2023\/06\/HIV-Myths-Facts-handout.pdf [Accessed 20 Feb 2025]."},{"key":"2026010805350669000_11.1.e020730.39","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200406010-00009"},{"key":"2026010805350669000_11.1.e020730.40","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000174655.63653.38"},{"key":"2026010805350669000_11.1.e020730.41","doi-asserted-by":"publisher","DOI":"10.7326\/M20-8251"},{"key":"2026010805350669000_11.1.e020730.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.03.020"},{"key":"2026010805350669000_11.1.e020730.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-15865-8","article-title":"Analysis of national physical activity and sedentary behaviour policies in China","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Public Health"},{"key":"2026010805350669000_11.1.e020730.44","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-024-01142-5","article-title":"\u201cI mean, it kind of saved my life, to be honest\u201d: a qualitative study of participants\u2019 views of a dialectical behaviour therapy for multidiagnostic eating disorders programme","volume":"12","author":"McColl","year":"2024","journal-title":"J Eat Disord"},{"key":"2026010805350669000_11.1.e020730.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2022.100210"},{"key":"2026010805350669000_11.1.e020730.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-20797-y","article-title":"Conspiracy narratives and vaccine hesitancy: a scoping review of prevalence, impact, and interventions","volume":"24","author":"Taubert","year":"2024","journal-title":"BMC Public Health"},{"key":"2026010805350669000_11.1.e020730.47","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-025-23754-5","article-title":"Understanding the rise of vaccine refusal: perceptions, fears, and influences","volume":"25","author":"U\u011frak","year":"2025","journal-title":"BMC Public Health"},{"key":"2026010805350669000_11.1.e020730.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267463","article-title":"Vaccination against misinformation: The inoculation technique reduces the continued influence effect","volume":"17","author":"Buczel","year":"2022","journal-title":"PLoS One"},{"key":"2026010805350669000_11.1.e020730.49","doi-asserted-by":"crossref","DOI":"10.1002\/gch2.201600008","article-title":"Inoculating the Public against Misinformation about Climate Change","volume":"1","author":"van der Linden","year":"2017","journal-title":"Glob Chall"},{"key":"2026010805350669000_11.1.e020730.50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0000000000003416","article-title":"Acceptability of a Future HIV Vaccine: A Rapid Scoping Review","volume":"96","author":"Choi","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026010805350669000_11.1.e020730.51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/008124630603600406","article-title":"Community Members\u2019 Perceptions of Enablers and Inhibitors to Participation in HIV Vaccine Trials","volume":"36","author":"Lesch","year":"2006","journal-title":"S Afr J Psychol"},{"key":"2026010805350669000_11.1.e020730.52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168660","article-title":"The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania","volume":"11","author":"Mbunda","year":"2016","journal-title":"PLoS One"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-020730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:35:18Z","timestamp":1767879318000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-020730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,8]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjgh-2025-020730"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-020730","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}